Tempo Scan Pacific Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tempo Scan Pacific Tbk PT with three other
pharmaceutical manufacturers in Asia:
Zhejiang Huahai Pharmaceutical
sales of 5.09 billion Chinese Renmimbi [US$741.88 million]
of which 57%
was Drug Sale),
Tong Ren Tang Technologies Company Limited
(5.06 billion Chinese Renmimbi [US$736.78 million]
of which 64%
was The Company), and
Center Laboratories Inc
based in Taiwan
(21.65 billion Taiwanese Dollars [US$722.40 million]
of which 91%
was Aoyou Department).
During the year ended December of 2018, sales at
Tempo Scan Pacific Tbk PT were 10.09 trillion Indonesian Rupiahs (US$740.47 million).
increase of 5.5%
versus 2017, when the company's sales were 9.57 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Tempo Scan Pacific Tbk PT
(and since 2013, sales have increased a total of 47%).
Sales of Consumer Products and Cosmetics saw an increase
that was more than double the company's growth rate: sales were up
14.2% in 2018, from
2.78 trillion Indonesian Rupiahs to 3.18 trillion Indonesian Rupiahs.
Tempo Scan Pacific Tbk PT also saw significant increases in sales in
Pharmaceuticals (up 10.5% to 2.62 trillion Indonesian Rupiahs)
Not all segments of Tempo Scan Pacific Tbk PT experienced an increase in sales in 2018:
sales of Distribution Services fell 2.7% to 4.29 trillion Indonesian Rupiahs.